These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3123402)

  • 41. Influence of the gonad on the degree of suppression induced by an LHRH agonist implant in the marmoset monkey.
    Lunn SF; Cowen GM; Morris KD; Fraser HM
    J Endocrinol; 1992 Feb; 132(2):217-24. PubMed ID: 1541921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A direct LHRH-agonist action on cancer cells is unlikely to be the cause of response to LHRH-agonist treatment.
    Slotman BJ; Poels LG; Rao BR
    Anticancer Res; 1989; 9(1):77-80. PubMed ID: 2495758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Temporal variations in testicular microcirculation.
    Bergh A; Lissbrant E; Collin O
    J Androl; 1999; 20(6):724-30. PubMed ID: 10591611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testicular microvascular blood flow: alteration after Leydig cell eradication and ischemia but not experimental varicocele.
    Turner TT; Caplis L; Miller DW
    J Androl; 1996; 17(3):239-48. PubMed ID: 8792214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of an LHRH analogue on testicular function in the immature monkey (Macaca mulatta).
    Arslan M; Khan SA; Qazi MH
    Int J Androl; 1982 Dec; 5(6):607-12. PubMed ID: 6819235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testicular microcirculation in the rat studied by videophotometric capillaroscopy, fluorescence microscopy and laser Doppler flowmetry.
    Damber JE; Bergh A; Fagrell B; Lindahl O; Rooth P
    Acta Physiol Scand; 1986 Mar; 126(3):371-6. PubMed ID: 2938420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of rats with hCG induces inflammation-like changes in the testicular microcirculation.
    Bergh A; Rooth P; Widmark A; Damber JE
    J Reprod Fertil; 1987 Jan; 79(1):135-43. PubMed ID: 3820165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testosterone supplementation attenuates the antifertility effects of an LHRH agonist in male rhesus monkeys.
    Akhtar FB; Marshall GR; Nieschlag E
    Int J Androl; 1983 Oct; 6(5):461-8. PubMed ID: 6418665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulatory effect of prolactin on luteinizing hormone-induced testicular 5 alpha-reductase activity in hypophysectomized adult rats.
    Takeyama M; Nagareda T; Takatsuka D; Namiki M; Koizumi K; Aono T; Matsumoto K
    Endocrinology; 1986 Jun; 118(6):2268-75. PubMed ID: 3486119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations.
    Stoeckemann K; Sandow J
    J Cancer Res Clin Oncol; 1993; 119(8):457-62. PubMed ID: 8509436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of testicular steroidogenesis by gonadotropin-releasing hormone agonists and antagonists.
    Huhtaniemi I; Nikula H; Rannikko S; Clayton R
    J Steroid Biochem; 1986 Jan; 24(1):169-76. PubMed ID: 3009972
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contraception with LHRH agonists, a new physiological approach.
    Labrie F; Séguin C; Bélanger A; Lefebvre FA; Massicotte J; Kelly PA; Pelletier G; Reeves JJ; Lemay A; Cusan L; Raynaud JP
    Reproduccion; 1981; 5(4):229-41. PubMed ID: 6274723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversibility of the effect of LHRH agonists and other antiandrogenic hormones on the testis: a histomorphometric study.
    Kisman OK; de Voogt HJ; Baak JA
    Eur Urol; 1990; 18(4):299-301. PubMed ID: 2127019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gonadotropin-releasing hormone agonist analog-induced steroidogenic lesion in the neonatal rat testis: evidence for direct gonadal action.
    Huhtaniemi IT; Clayton RN; Catt KJ
    Endocrinology; 1984 Jul; 115(1):233-8. PubMed ID: 6329649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Cusan L; Raynaud JP; Husson JM; Fazekas AT
    Horm Res; 1983; 18(1-3):18-27. PubMed ID: 6411578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are leukocytes involved in the human chorionic gonadotropin-induced increase in testicular vascular permeability?
    Bergh A; Widmark A; Damber JE; Cajander S
    Endocrinology; 1986 Aug; 119(2):586-90. PubMed ID: 3732138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of testicular macrophages in the response of Leydig cells to gonadotrophins in young hypophysectomized rats.
    Gaytan F; Bellido C; Morales C; van Rooijen N; Aguilar E
    J Endocrinol; 1995 Dec; 147(3):463-71. PubMed ID: 8543916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
    Schuiling GA; Pols-Valkhof N; van der Schaaf-Verdonk GC; Koiter TR
    J Endocrinol; 1984 Dec; 103(3):301-9. PubMed ID: 6438265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of testicular blood flow and focal degeneration of tissue in the rat after administration of human chorionic gonadotrophin.
    van Vliet J; Rommerts FF; de Rooij DG; Buwalda G; Wensing CJ
    J Endocrinol; 1988 Apr; 117(1):51-7. PubMed ID: 2833552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.